Literature DB >> 2813386

Searching for pharmacophores in large coordinate data bases and its use in drug design.

R P Sheridan1, A Rusinko, R Nilakantan, R Venkataraghavan.   

Abstract

Pharmacophores, three-dimensional arrangements of chemical groups essential for biological activity, are being proposed in increasing numbers. We have developed a system to search data bases of three-dimensional coordinates for compounds that contain a particular pharmacophore. The coordinates can be derived from experiment (e.g., Cambridge Crystal Database) or be generated from data bases of connection tables (e.g., Cyanamid Laboratories proprietary compounds) via the program CONCORD. We discuss the results of searches for three sample pharmacophores. Two have been proposed by others based on the conformational analysis of active compounds, and one is inferred from the crystal structure of a protein-ligand complex. These examples show that such searches can identify classes of compounds that are structurally different from the compounds from which the pharmacophore was derived but are known to have the appropriate biological activity. Occasionally, the searches find bond "frameworks" in which the important groups are rigidly held in the proper geometry. These may suggest new structural classes for synthesis.

Mesh:

Substances:

Year:  1989        PMID: 2813386      PMCID: PMC298236          DOI: 10.1073/pnas.86.20.8165

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  The Protein Data Bank: a computer-based archival file for macromolecular structures.

Authors:  F C Bernstein; T F Koetzle; G J Williams; E F Meyer; M D Brice; J R Rodgers; O Kennard; T Shimanouchi; M Tasumi
Journal:  J Mol Biol       Date:  1977-05-25       Impact factor: 5.469

2.  The ensemble approach to distance geometry: application to the nicotinic pharmacophore.

Authors:  R P Sheridan; R Nilakantan; J S Dixon; R Venkataraghavan
Journal:  J Med Chem       Date:  1986-06       Impact factor: 7.446

3.  A common structural model for central nervous system drugs and their receptors.

Authors:  E J Lloyd; P R Andrews
Journal:  J Med Chem       Date:  1986-04       Impact factor: 7.446

4.  MENTHOR, a database system for the storage and retrieval of three-dimensional molecular structures and associated data searchable by substructural, biologic, physical, or geometric properties.

Authors:  Y C Martin; E B Danaher; C S May; D Weininger
Journal:  J Comput Aided Mol Des       Date:  1988-04       Impact factor: 3.686

5.  The design of a new group of angiotensin-converting enzyme inhibitors.

Authors:  C H Hassall; A Kröhn; C J Moody; W A Thomas
Journal:  FEBS Lett       Date:  1982-10-18       Impact factor: 4.124

6.  Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.

Authors:  H S Cheung; F L Wang; M A Ondetti; E F Sabo; D W Cushman
Journal:  J Biol Chem       Date:  1980-01-25       Impact factor: 5.157

7.  Distance geometry approach to rationalizing binding data.

Authors:  G M Crippen
Journal:  J Med Chem       Date:  1979-08       Impact factor: 7.446

8.  Antihypertensive agents: angiotensin converting enzyme inhibitors. 1-[3-(Acylthio)-3-aroylpropionyl]-L-prolines.

Authors:  F J McEvoy; F M Lai; J D Albright
Journal:  J Med Chem       Date:  1983-03       Impact factor: 7.446

9.  The three-dimensional structure of trp repressor.

Authors:  R W Schevitz; Z Otwinowski; A Joachimiak; C L Lawson; P B Sigler
Journal:  Nature       Date:  1985 Oct 31-Nov 6       Impact factor: 49.962

10.  A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies.

Authors:  D Mayer; C B Naylor; I Motoc; G R Marshall
Journal:  J Comput Aided Mol Des       Date:  1987-04       Impact factor: 3.686

  10 in total
  12 in total

1.  Designing the molecular future.

Authors:  Gisbert Schneider
Journal:  J Comput Aided Mol Des       Date:  2011-11-30       Impact factor: 3.686

2.  In search of new lead compounds for trypanosomiasis drug design: a protein structure-based linked-fragment approach.

Authors:  C L Verlinde; G Rudenko; W G Hol
Journal:  J Comput Aided Mol Des       Date:  1992-04       Impact factor: 3.686

3.  The role of structure-based ligand design and molecular modelling in drug discovery.

Authors:  J P Tollenaere
Journal:  Pharm World Sci       Date:  1996-04

4.  Database diversity assessment: new ideas, concepts, and tools.

Authors:  R Nilakantan; N Bauman; K S Haraki
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

5.  DBMAKER: a set of programs to generate three-dimensional databases based upon user-specified criteria.

Authors:  C M Ho; G R Marshall
Journal:  J Comput Aided Mol Des       Date:  1995-02       Impact factor: 3.686

6.  FOUNDATION: a program to retrieve all possible structures containing a user-defined minimum number of matching query elements from three-dimensional databases.

Authors:  C M Ho; G R Marshall
Journal:  J Comput Aided Mol Des       Date:  1993-02       Impact factor: 3.686

7.  GenStar: a method for de novo drug design.

Authors:  S H Rotstein; M A Murcko
Journal:  J Comput Aided Mol Des       Date:  1993-02       Impact factor: 3.686

Review 8.  Strategies for indirect computer-aided drug design.

Authors:  G H Loew; H O Villar; I Alkorta
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

9.  Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro.

Authors:  F McPhee; P S Caldera; G W Bemis; A F McDonagh; I D Kuntz; C S Craik
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

10.  PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach.

Authors:  Xiaofeng Liu; Sisheng Ouyang; Biao Yu; Yabo Liu; Kai Huang; Jiayu Gong; Siyuan Zheng; Zhihua Li; Honglin Li; Hualiang Jiang
Journal:  Nucleic Acids Res       Date:  2010-04-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.